Purchase Order 75N92B20P00039
Award Date 7/31/20
Potential Completion Date 8/31/22
Potential Value $7.5K
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35205, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract, valued at $47,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Southern Research Institute, a non-profit organization, for COVID-19 compound dose response testing. The contract has no set-aside designation and is part of NCATS' efforts to evaluate potential COVID-19 treatments. Southern Research Institute has a history of providing drug discovery, development, and testing services to...
- This is a $37,000.00 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, part of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for compound testing and cytotoxicity screening related to SARS-CoV-2. The contract does not have a set-aside designation. Through past federal contracts and grants, Southern Research has provided a range of research and development services...
- This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Southern Research Institute to conduct COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 cytopathic effect (CPE) assay across two rounds. The $74,000.00 contract has an ultimate completion date of August 28, 2020 and was not set aside for any specific business type. Southern Research Institute is a...
- This is a $37,522 Firm Fixed Price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is to provide in vitro assessment for antimicrobial activity, and is part of the broader In Vitro Antimicrobial Assessments 2011-2018 IDIQ contract vehicle. Southern Research Institute has extensive experience providing research and development...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization, for $544,721.00. The order is for in vitro assessments of antimicrobial activity, and is placed under NIAID's broader In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The award does not have a set-aside designation. Through past prime and...
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to the Southern Research Institute, a non-profit research organization. The $42,000 contract is for COVID-19 compound testing and cytotoxicity screening in the SARS-CoV-2 CPE assay. This work supports NCATS' mission of advancing the translation of medical discoveries into clinical applications. The contract has no...
- This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract, valued at $26,480.00, is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and was awarded under the "In Vitro Antimicrobial Assessments 2011-2018" indefinite delivery/indefinite...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Southern Research Institute. The order is part of the In Vitro Antimicrobial Assessments 2011-2018 indefinite delivery/indefinite quantity (IDIQ) contract vehicle, valued at a ceiling of $410,090.00. The order is for in vitro antimicrobial assessment services, with a period of performance through February 28, 2013. Southern Research...
- This federal contract award of $331,397 was issued by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit research organization, to perform computational docking and synthesis of optimized analogs of the orthopoxvirus small molecule inhibitor ST-357. The award is a delivery order under the agency's Nonclinical Services for Development of Interventional Agents contract...
- This is a $8,755.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization. The contract has no set-aside designation and was awarded on August 15, 2012, with a completion date of November 30, 2012. Southern Research Institute, doing business as Southern Research, has experience providing drug discovery and development, infectious disease research, and other...